07/08/2025 4:00 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2025 7:45 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2025 7:00 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
06/09/2025 4:29 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2025 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2025 4:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 6:30 AM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
04/28/2025 6:32 AM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
04/02/2025 6:27 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
03/10/2025 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for CTXR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
02/06/2025 8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2025 3:05 PM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
01/27/2025 3:07 PM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
01/16/2025 3:30 PM | Citius Pharmaceuticals (Filer)
| Form PRE 14A | |
01/08/2025 3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 8:00 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
01/07/2025 8:11 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2024 4:10 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2024 4:00 PM | Citius Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/20/2024 3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2024 3:05 PM | Citius Pharmaceuticals (Subject) Mazur Leonard L (Filed by)
| Form SC 13D/A | |
11/25/2024 4:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 7:30 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Holuka Eugene Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) MCGRATH DENNIS M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Dutia Suren G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Czuczman Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Mazur Leonard L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Bartushak Jaime (Reporting) Citius Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Smith Robert Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 4:00 PM | Citius Pharmaceuticals (Issuer) Webb Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2024 4:26 PM | Citius Pharmaceuticals (Issuer) Mazur Leonard L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 4:27 PM | Citius Pharmaceuticals (Issuer) HOLUBIAK MYRON Z (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 7:30 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 4:26 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2024 3:01 PM | Citius Pharmaceuticals (Issuer) Webb Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
08/30/2024 3:01 PM | Citius Pharmaceuticals (Issuer) Holuka Eugene Myron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 3:34 PM | CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) CITIUS ONCOLOGY, INC. (Subject) Citius Pharmaceuticals (Filed by)
| Form SC 13D | |
08/16/2024 3:35 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 5:19 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Pharmaceuticals (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:25 PM | CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) CITIUS ONCOLOGY, INC. (Issuer) Citius Pharmaceuticals (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:10 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024 4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 3:51 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |